Medullary sponge kidney
MSK · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Congenital cystic dilatation of the medullary collecting ducts causing nephrocalcinosis, recurrent calcium stones and incomplete distal renal tubular acidosis. Generally benign with preserved function, managed with stone prevention and infection control.
Red flags
- Recurrent febrile UTIs / pyelonephritis
- Obstructing stone with infection
- Declining renal function (atypical — reconsider diagnosis)
- Severe refractory hypercalciuria
- Gross haematuria needing urological evaluation
Assessment
Differential diagnosis
- Nephrocalcinosis from other cause (hyperparathyroidism, dRTA, hypercalciuria)
- Papillary necrosis
- Autosomal dominant polycystic kidney disease
- Medullary cystic kidney disease / ADTKD
- Recurrent idiopathic nephrolithiasis
- Chronic pyelonephritis
Investigations
- CT urogram / contrast imaging (medullary nephrocalcinosis, 'paintbrush' ductal striations)
- Ultrasound (medullary nephrocalcinosis)
- 24-hour urine metabolic profile (hypercalciuria, hypocitraturia)
- Urine pH and acid-load test (incomplete distal RTA)
- Serum calcium, PTH, bicarbonate
- Urine culture
Management
- Confirm diagnosis radiologically (medullary cystic ectasia with nephrocalcinosis)
- Exclude other causes of medullary nephrocalcinosis (hyperparathyroidism, complete dRTA)
- Perform a metabolic stone work-up (24-hour urine) as these patients are recurrent calcium stone formers
- Advise high fluid intake targeting urine output >2.5 L/day
- Treat hypercalciuria with a thiazide diuretic
- Correct hypocitraturia/incomplete distal RTA with potassium citrate
- Treat and prevent urinary tract infections promptly
- Manage symptomatic stones with standard urological techniques
- Reassure regarding generally benign prognosis and usually preserved renal function
- Monitor renal function, stone recurrence and infections periodically
- Screen for and manage any superimposed metabolic disorders
- Provide long-term follow-up for stone prevention
Drugs & doses
Potassium citrate 10-20 mEq PO two to three times daily (hypocitraturia/incomplete dRTA)
Hydrochlorothiazide 25 mg PO daily (hypercalciuria)
Culture-directed antibiotics for UTIs
Disposition
Outpatient nephrology/urology stone clinic. Standard urological management for symptomatic stones. Reassurance and long-term prevention.
Complications & pitfalls
- Recurrent calcium stones
- Recurrent urinary tract infections
- Incomplete distal renal tubular acidosis
- Rarely progressive CKD
- Haematuria
Exam pearls
- Think MSK in young recurrent calcium stone formers with medullary nephrocalcinosis
- Incomplete distal RTA is common and responds to potassium citrate
- Prognosis is usually excellent with preserved renal function
- Metabolic stone work-up guides prevention
- Distinguish from complete dRTA and hyperparathyroidism before labelling
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.